Skip to content

The Effect of Oral Contraceptive Pills on Disease Activity in Women with Rheumatoid Arthritis, Tehran, 2010-2011

The Effect of Oral Contraceptive Pills on Disease Activity in Women with Rheumatoid Arthritis, Tehran, 2010-2011

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138904224364N1
Enrollment
100
Registered
2011-07-24
Start date
2010-08-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis. Rheumatoid arthritis, unspecified

Interventions

Intervention 1: Intervention: Low dose oral Contraceptives Pills administration as routine for 2 cycles in order to contraceptive purpose. Intervention 2: Control: Without any intervention.
Prevention
Intervention: Low dose oral Contraceptives Pills administration as routine for 2 cycles in order to contraceptive purpose

Sponsors

Vice chancellor for research Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : healthy women without any other physical or mental diseases ; oral contraception contraindications; no changes in patient's medication regimen during last three monts; no decision for pregnancy; suspicion of pregnancy; giving medical treatment,no use OCPs during last 6 months - Exclusion criteria of the study are: Complications detection such as severe nausea and vomiting; because of pills; high risk patients for OCPs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Rheumatoid Arthritis disease activity. Timepoint: Befor and 2 months after study. Method of measurement: Instrument DAS-28.

Secondary

MeasureTime frame
-. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Amini

Faculty of Nursing and Midwifery Tehran

l-amini@tums.ac.ir+98 21 6105 4225

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026